TAK CapEx to Revenue

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · CapEx to Revenue

TAK logo

TAK CapEx to Revenue

Current (TTM)4.21%
TAK CapEx/Revenue (3.84% → 4.21%)
High-resolution chart · PNG

TAK capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.9062%
4.3827%
4.1142%
3.4924%
3.4534%
3.4776%
3.8613%
3.7038%
3.7845%
3.5599%
2.6977%
2.713%
2.962%
5.3588%
4.1025%
8.7478%
5.9319%
2.5654%
2.3726%
2.2335%
2.6475%
4.7792%
4.9851%
3.2002%
3.7334%
2.7962%
3.8373%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.